The 1 analysts offering 12-month price forecasts for Aytu Biopharma Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +206.75% increase from the last price of 1.63.
The current consensus among 1 polled investment analysts is to Buy stock in Aytu Biopharma Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.54
Reporting Date Sep 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.